Iterum Therapeutics plc (ITRMF) Return on Invested Capital (2019 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Return on Invested Capital of 0.01% for Q3 2025, up 1.0% year-over-year from 0.01% in Q3 2024, and up 135.45% quarter-over-quarter from 0.02% in Q2 2025.
Iterum Therapeutics plc (ITRMF) Return on Invested Capital (2019 - 2025) Analysis & Trends
Iterum Therapeutics' Return on Invested Capital history runs 6 years deep, the most recent figure standing at 0.01% for Q3 2025.
- In Q3 2025, Return on Invested Capital rose 1.0% year-over-year to 0.01%; the TTM figure through Sep 2025 stood at 0.01% (up 1.0% YoY), while the FY2021 annual figure was 0.06%, down 5.0% from the prior year.
- Return on Invested Capital for Q3 2025 stood at 0.01%, up from 0.02% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q3 2025, with the low at 0.09% in Q3 2022.
- The 4-year median for Return on Invested Capital is 0.01% (2021), against an average of 0.02%.
- The sharpest annual moves came in 2021 and 2022: Return on Invested Capital grew 4 bps in 2021, then declined 8 bps in 2022.
- Iterum Therapeutics' Return on Invested Capital stood at 0.01% in 2021, then slumped by 581 bps to 0.09% in 2022, then soared by 59 bps to 0.04% in 2024, then soared by 118 bps to 0.01% in 2025.
- Business Quant data shows ITRMF's Return on Invested Capital at 0.01% in Q3 2025, 0.02% in Q2 2025, and 0.01% in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.02% |
| Sep 30, 2022 | -0.09% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | -0.02% |
| Jun 30, 2020 | -0.04% |
| Mar 31, 2020 | -0.05% |
| Dec 31, 2019 | -0.07% |
| Sep 30, 2019 | -0.11% |
| Jun 30, 2019 | -0.20% |